| Species |
hsa |
mmu |
rno |
dre |
mcc |
cfa |
fca |
| Symbol |
LYPD6B |
Lypd6b |
Lypd6b |
lypd6b |
LYPD6B |
LYPD6B |
LYPD6B |
| Function* |
LY6/PLAUR domain containing 6B |
LY6/PLAUR domain containing 6B |
LY6/PLAUR domain containing 6B |
LY6/PLAUR domain containing 6B |
LY6/PLAUR domain containing 6B |
LY6/PLAUR domain containing 6B |
LY6/PLAUR domain containing 6B |
| Expression |
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
Expression pattern for all samples
|
| Umap |
|
|
|
|
|
|
|
| Coexpression |
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| hsa04080 |
Neuroactive ligand-receptor interaction |
2 |
 |
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| mmu04360 |
Axon guidance |
2 |
|
| mmu04390 |
Hippo signaling pathway |
2 |
 |
| mmu04530 |
Tight junction |
2 |
 |
| mmu05160 |
Hepatitis C |
2 |
 |
| mmu05150 |
Staphylococcus aureus infection |
2 |
 |
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| rno04080 |
Neuroactive ligand-receptor interaction |
11 |
|
| rno04020 |
Calcium signaling pathway |
3 |
|
| rno04072 |
Phospholipase D signaling pathway |
2 |
|
| rno04724 |
Glutamatergic synapse |
2 |
|
| rno04915 |
Estrogen signaling pathway |
2 |
|
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| mcc04080 |
Neuroactive ligand-receptor interaction |
2 |
|
| mcc04020 |
Calcium signaling pathway |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| cfa04080 |
Neuroactive ligand-receptor interaction |
2 |
|
|
| KEGG* ID |
Title |
#genes |
Link to the KEGG* map
(Multiple genes) |
| fca04080 |
Neuroactive ligand-receptor interaction |
4 |
|
| fca00062 |
Fatty acid elongation |
2 |
|
| fca01040 |
Biosynthesis of unsaturated fatty acids |
2 |
|
| fca01212 |
Fatty acid metabolism |
2 |
|
| fca04020 |
Calcium signaling pathway |
2 |
|
|
| GO BP* |
|
|
|
|
|
|
|
| GO CC* |
|
GO:0031225 [L] [N] anchored component of membrane
|
(100 genes)
|
|
GO:0005576 [L] [N] extracellular region
|
(1946 genes)
|
|
GO:0005886 [L] [N] plasma membrane
|
(4709 genes)
|
|
|
GO:0031225 [L] [N] anchored component of membrane
|
(155 genes)
|
|
GO:0005886 [L] [N] plasma membrane
|
(4367 genes)
|
|
GO:0016020 [L] [N] membrane
|
(6651 genes)
|
|
|
GO:0005886 [L] [N] plasma membrane
|
(4480 genes)
|
|
GO:0016021 [L] [N] integral component of membrane
|
(5025 genes)
|
|
|
GO:0005886 [L] [N] plasma membrane
|
(2317 genes)
|
|
GO:0016020 [L] [N] membrane
|
(6986 genes)
|
|
|
|
|
| GO MF* |
|
GO:0030548 [L] [N] acetylcholine receptor regulator activity
|
(9 genes)
|
|
|
GO:0030548 [L] [N] acetylcholine receptor regulator activity
|
(10 genes)
|
|
|
GO:0030548 [L] [N] acetylcholine receptor regulator activity
|
(9 genes)
|
|
|
GO:0030548 [L] [N] acetylcholine receptor regulator activity
|
(2 genes)
|
|
|
|
|
| KEGG* |
| 04080 |
Neuroactive ligand-receptor interaction |
 |
|
| 04080 |
Neuroactive ligand-receptor interaction |
|
|
| 04080 |
Neuroactive ligand-receptor interaction |
|
|
| 04080 |
Neuroactive ligand-receptor interaction |
|
|
| 04080 |
Neuroactive ligand-receptor interaction |
|
|
| 04080 |
Neuroactive ligand-receptor interaction |
|
|
| 04080 |
Neuroactive ligand-receptor interaction |
|
|
| Entrez Gene ID* |
130576 |
71897 |
362133 |
554606 |
693727 |
100686612 |
101084896 |
